Recruiting PHASE4 INTERVENTIONAL 4-arm NCT06013956

Personalized Real-Time DBS and PD Mechanisms

Identifying Circuit Dynamics Underlying Motor Dysfunction in Parkinson's Disease Using Real-Time Neural Control

Sponsor: David Escobar

Interventions Carbidopa 25/Levodopa 100Mg Tab Neurostimulation

Updated 6 times since 2023 Last updated: May 11, 2025 Started: Aug 29, 2023 Primary completion: Jun 30, 2028 Completion: Jun 30, 2028

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Parkinson Disease and is currently actively recruiting participants. David Escobar leads this study, which shows 6 recorded versions since 2023 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Jun 2025 — Present [monthly]

Recruiting PHASE4
Feb 2025 — Jun 2025 [monthly]

Recruiting PHASE4
Sep 2024 — Feb 2025 [monthly]

Recruiting PHASE4
Jul 2024 — Sep 2024 [monthly]

Recruiting PHASE4
Jan 2024 — Jul 2024 [monthly]

Recruiting PHASE4

▶ Show 1 earlier version

Sep 2023 — Jan 2024 [monthly]

Recruiting PHASE4

First recorded

Aug 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

David Escobar
The Cleveland Clinic

Data source: The Cleveland Clinic

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Cleveland, United States